Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases
2004 Monetti F; Casanova S; Grasso A; Cafferata MA; Ardizzoni A; Neumaier CE
Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers
2010 Tiseo M; Rossi G; Capelletti M; Sartori G; Spiritelli E; Marchioni A; Bozzetti C; De Palma G; Lagrasta C; Campanini N; Camisa R; Boni L; Franciosi V; Rindi G; Ardizzoni A
Is Cytology Reliable for Epidermal Growth Factor Receptor Gene Evaluation in Non-small Cell Lung Cancer?
2010 Bozzetti C; Tiseo M; Lagrasta C; Nizzoli R; Guazzi A; Graiani G; Rindi G; Ardizzoni A
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
2004 Gatzemeier U; Groth G; Butts C; Van Zandwijk N; Shepherd F; Ardizzoni A; Barton C; Ghahramani P; Hirsh V
Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis
2007 Ardizzoni A; Boni L; Tiseo M; Fossella FV; Schiller JH; Paesmans M; Radosavljevic D; Paccagnella A; Zatloukal P; Mazzanti P; Bisset D; Rosell R
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
2009 La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Ardizzoni A; Tiseo M; Capelletti M; Goldoni M; Tagliaferri S; Mutti A; Fumarola C; Bonelli M; Generali D; Petronini PG
Current status of second-line treatment and novel therapies for small cell lung cancer
2007 Tiseo M; Ardizzoni A
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study
2005 Musolino A; Michiara M; Bella MA; Naldi N; Zanelli P; Bortesi B; Capelletti M; Soldani L; Camisa R; Martella E; Franciosi V; Savi M; Neri TM; Ardizzoni A; Cascinu S
Dramatic responses to therapy in rare tumors
2005 Tiseo M; Monetti E; Ferrarini M; Serrano J; Chiaramondia M; Ardizzoni A
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: Does cisplatin versus carboplatin make a difference?
2005 Tiseo M; Boni L; Ardizzoni A
Predictors of clinical response of non-small cell cancer to gefitinib
2004 Ardizzoni A; Tiseo M
Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report
2009 Tiseo M; Gelsomino F; Bartolotti M; Barili MP; Ardizzoni A
HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis
2011 Negri FV; Bozzetti C; Ardizzoni A; Lagrasta C; Crafa P; Silini EM
PTEN status in advanced colorectal cancer treated with cetuximab
2010 F.NEGRI; C. BOZZETTI; CA. LAGRASTA; P. CRAFA; MP. BONASONI; R. CAMISA; G. PEDRAZZI; ARDIZZONI A
Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma
2007 Palmerini, Emanuela; Ferrari, Stefano; Bertoni, Franco; Bacci, Gaetano
Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma
2011 Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
2010 Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy
2009 Tiseo M; Gridelli C; Cascinu S; Crino L; Piantedosi FV; Grossi F; Brandes AA; Labianca R; Siena S; Amoroso D; Belvedere O; Valentino B; Bearz A; Venturino P; Ardizzoni A
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
2008 Musolino A; Naldi N; Bortesi B; Pezzuolo D; Capelletti M; Missale G; Laccabue D; Zerbini A; Camisa R; Bisagni G; Neri TM; Ardizzoni A
Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer
2008 Tiseo M; Ardizzoni A; Cafferata MA; Loprevite M; Chiaramondia M; Filiberti R; Marroni P; Gross F; Paganuzzi M
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases | Monetti F; Casanova S; Grasso A; Cafferata MA; Ardizzoni A; Neumaier CE | 2004-01-01 | LUNG CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers | Tiseo M; Rossi G; Capelletti M; Sartori G; Spiritelli E; Marchioni A; Bozzetti C; De Palma G; Lag...rasta C; Campanini N; Camisa R; Boni L; Franciosi V; Rindi G; Ardizzoni A | 2010-01-01 | LUNG CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Is Cytology Reliable for Epidermal Growth Factor Receptor Gene Evaluation in Non-small Cell Lung Cancer? | Bozzetti C; Tiseo M; Lagrasta C; Nizzoli R; Guazzi A; Graiani G; Rindi G; Ardizzoni A | 2010-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer | Gatzemeier U; Groth G; Butts C; Van Zandwijk N; Shepherd F; Ardizzoni A; Barton C; Ghahramani P; ...Hirsh V | 2004-01-01 | ANNALS OF ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis | Ardizzoni A; Boni L; Tiseo M; Fossella FV; Schiller JH; Paesmans M; Radosavljevic D; Paccagnella ...A; Zatloukal P; Mazzanti P; Bisset D; Rosell R | 2007-01-01 | JOURNAL OF THE NATIONAL CANCER INSTITUTE | - | 1.04 Replica / breve intervento (e simili) | - |
| Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines | La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Ardizzoni A; Tiseo M; Capelletti M; Goldoni M; T...agliaferri S; Mutti A; Fumarola C; Bonelli M; Generali D; Petronini PG | 2009-01-01 | BIOCHEMICAL PHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Current status of second-line treatment and novel therapies for small cell lung cancer | Tiseo M; Ardizzoni A | 2007-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study | Musolino A; Michiara M; Bella MA; Naldi N; Zanelli P; Bortesi B; Capelletti M; Soldani L; Camisa ...R; Martella E; Franciosi V; Savi M; Neri TM; Ardizzoni A; Cascinu S | 2005-01-01 | TUMORI | - | 1.04 Replica / breve intervento (e simili) | - |
| Dramatic responses to therapy in rare tumors | Tiseo M; Monetti E; Ferrarini M; Serrano J; Chiaramondia M; Ardizzoni A | 2005-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: Does cisplatin versus carboplatin make a difference? | Tiseo M; Boni L; Ardizzoni A | 2005-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Predictors of clinical response of non-small cell cancer to gefitinib | Ardizzoni A; Tiseo M | 2004-01-01 | JAMA | - | 1.04 Replica / breve intervento (e simili) | - |
| Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report | Tiseo M; Gelsomino F; Bartolotti M; Barili MP; Ardizzoni A | 2009-01-01 | LUNG CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis | Negri FV; Bozzetti C; Ardizzoni A; Lagrasta C; Crafa P; Silini EM | 2011-01-01 | HUMAN PATHOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| PTEN status in advanced colorectal cancer treated with cetuximab | F.NEGRI; C. BOZZETTI; CA. LAGRASTA; P. CRAFA; MP. BONASONI; R. CAMISA; G. PEDRAZZI; ARDIZZONI A | 2010-01-01 | BRITISH JOURNAL OF CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma | Palmerini, Emanuela; Ferrari, Stefano; Bertoni, Franco; Bacci, Gaetano | 2007-01-01 | CLINICAL ORTHOPAEDICS AND RELATED RESEARCH | - | 1.04 Replica / breve intervento (e simili) | - |
| Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma | Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A | 2011-01-01 | CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology | Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shephe...rd FA; De Petris L; Di Maio M; de Marinis F | 2010-01-01 | LUNG CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy | Tiseo M; Gridelli C; Cascinu S; Crino L; Piantedosi FV; Grossi F; Brandes AA; Labianca R; Siena S...; Amoroso D; Belvedere O; Valentino B; Bearz A; Venturino P; Ardizzoni A | 2009-01-01 | LUNG CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer | Musolino A; Naldi N; Bortesi B; Pezzuolo D; Capelletti M; Missale G; Laccabue D; Zerbini A; Camis...a R; Bisagni G; Neri TM; Ardizzoni A | 2008-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer | Tiseo M; Ardizzoni A; Cafferata MA; Loprevite M; Chiaramondia M; Filiberti R; Marroni P; Gross F;... Paganuzzi M | 2008-01-01 | ANTICANCER RESEARCH | - | 1.04 Replica / breve intervento (e simili) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 - Contributo in rivista3997
Data di pubblicazione
- In stampa/Attività in corso2
- 2020 - 2026938
- 2010 - 20191982
- 2000 - 20091057
- 1990 - 199917
- 1987 - 19891
Rivista
- EUROPRESSRESEARCH103
- IL DIRITTO MARITTIMO43
- QUADERNI COSTITUZIONALI42
- IL GIORNALE DELL'ARCHITETTURA41
- INTENSIVE CARE MEDICINE37
- ECONOMIA AGRO-ALIMENTARE32
- IL MULINO26
- DIGESTIVE AND LIVER DISEASE25
- I MARTEDÌ25
- FONDERIA PRESSOFUSIONE23
Keyword
- Humans224
- Male64
- Female63
- n/a56
- editorial35
- biodiversity34
- Medicine (all)33
- COVID-1931
- Italy31
- remote sensing31
Lingua
- eng2572
- ita1412
- fre28
- spa26
- ger11
- por5
- rus4
- und3
- ara1
- cat1
Accesso al fulltext
- no fulltext3581
- open345
- reserved65
- embargoed4
- partially open2